Cell and Gene Therapy Catapult

Activities: Cell & Gene Therapy

Trending Articles

  1. Ardena to expand US footprint with the acquisition of advanced drug product manufacturing facility from Catalent Ardena, a specialist pharmaceutical CDMO with GMP facilities in Belgium, Spain, the Netherlands and Sweden, has signed a definitive agreement to acquire Catalent’s...
  2. Nuclera raises $75m to bolster its protein discovery platform The eProtein Discovery system is designed to speed up protein expression and purification by automating construct screening
  3. Thermo Fisher Scientific launches ambient antibody packaging shipping solution The new sustainable packaging solution allows the ambient distribution of therapeutic antibodies to customers
  4. Natac obtains the GMP certificate to manufacture for the pharmaceutical sector The GMP certificate will allow the manufacturing site in Hervás, Cáceres to manufaacture active ingredients for the pharmaceutical industry that is based on medicinal plants
  5. Maximise your automatic filling process in hazardous areas Discover how the IND500x ensures both safety and productivity in Zone 1/21 environments

Upcoming event

Lab Innovations

30-31 October 2024 | Exhibition | Birmingham, UK See all

Related Content

Finance

Horiba joins cell & gene therapy manufacturing consortium

Headed by the Cell and Gene Therapy Catapult, the consortium comprises technology providers, pharmaceutical companies, therapy developers and charities
Regulatory

NHC named National Training Centre for UK skills initiative

The National Horizons Centre will provide hands-on training for advanced therapy medicinal products (ATMPs) and vaccine manufacture
Finance

Stevenage cell and gene therapy facility receives £3m government grant

The cell and gene therapy cluster around Stevenage has reportedly been recognised as a high potential opportunity zone, set to attract overseas investment to the
Regulatory

CGT Catapult analyses manufacturing and skills in cell and gene therapy

New data has shown cell and gene therapy manufacturing facilities are rapidly becoming operational reflecting job expansion in the sector
Media

British cell and gene therapy accelerator releases annual report

The CGT Catapult has worked on more than 110 projects addressing industry challenges
Research & Development

CGT Catapult brings SMEs together

Fujifilm Diosynth, Eversheds Sutherland, Mathys & Squire and Stifel gather at CGT Catapult’s first UK Advanced Therapy Medicinal Products Investor Day
Research & Development

TCR2 Therapeutics and CGT Catapult join forces at UK Bioscience park

TCR<sup>2</sup> is the first US company to have a global development base at the Stevenage site, working with CGT Catapult to further its T cell therapies
Subscribe now